Free Trial
LON:DXRX

Diaceutics (DXRX) Share Price, News & Analysis

Diaceutics logo
GBX 118 -3.00 (-2.48%)
As of 04/2/2025 12:33 PM Eastern

About Diaceutics Stock (LON:DXRX)

Key Stats

Today's Range
117.50
122
50-Day Range
118
146.50
52-Week Range
95
151
Volume
29,167 shs
Average Volume
111,549 shs
Market Capitalization
£99.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 160
Consensus Rating
Buy

Company Overview

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network®.

Remove Ads
Receive DXRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter.

DXRX Stock News Headlines

New “Trump” currency proposed in DC
According to one of the most connected men in Washington… A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note. All to celebrate a new “golden age” for America.
Diaceutics PLC Announces Major Shareholding Change
Diaceutics Expands US Market with New Partnerships
See More Headlines

DXRX Stock Analysis - Frequently Asked Questions

Diaceutics' stock was trading at GBX 123 at the start of the year. Since then, DXRX shares have decreased by 4.1% and is now trading at GBX 118.
View the best growth stocks for 2025 here
.

Shares of DXRX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Diaceutics investors own include 4D pharma (DDDD), Rolls-Royce Holdings plc (RR.L), Abcam (ABC), B&M European Value Retail (BME), BP (BP), Coats Group (COA) and genedrive (GDR).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
LON:DXRX
CIK
N/A
Phone
N/A
Fax
N/A
Employees
151
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
GBX 160
High Stock Price Target
GBX 160
Low Stock Price Target
GBX 160
Potential Upside/Downside
+35.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
116.74
P/E Growth
N/A
Net Income
£-2,843,065.67
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£26.08 million
Cash Flow
GBX 37.82 per share
Price / Cash Flow
3.12
Book Value
GBX 45.87 per share
Price / Book
2.57

Miscellaneous

Free Float
N/A
Market Cap
£99.58 million
Optionable
Not Optionable
Beta
0.58
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (LON:DXRX) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners